Tri Ri Asset Management Corp Neurocrine Biosciences Inc Transaction History
Tri Ri Asset Management Corp
- $136 Billion
- Q3 2024
A detailed history of Tri Ri Asset Management Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Tri Ri Asset Management Corp holds 28,088 shares of NBIX stock, worth $3.92 Million. This represents 2.29% of its overall portfolio holdings.
Number of Shares
28,088Holding current value
$3.92 Million% of portfolio
2.29%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.98 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.39 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$718 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$359 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$260 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...